Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT02897167
Eligibility Criteria:
Inclusion Criteria:
* Patients included in the First Episode Psychosis Clinical Program (PAFIP) between June 2011 and September 2017.
* Living in the catchment area.
* Experiencing their first episode of psychosis before 40 years.
* Meeting Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-V) criteria for a principal diagnosis of schizophreniform, schizophrenia, schizoaffective, brief reactive psychosis, or psychosis non otherwise specified.
* No prior treatment with antipsychotic medication or, if previously treated, a total life time of adequate antipsychotic treatment of less than 6 weeks.
Exclusion Criteria:
* Meeting DSM-V criteria for drug dependence.
* Meeting DSM-V criteria for mental retardation.
* Having a history of neurological disease or head injury.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
15 Years
Maximum Age:
50 Years
Study:
NCT02897167
Study Brief:
Protocol Section:
NCT02897167